Journals / Türk Geriatri Dergisi / 2012 / Cilt: 15 - Sayı: 4

Antalya'da 65 yaş ve üzerindeki bireylerde grip aşısı ile bağışıklanma durumu

Influenza vaccınatıon ın 65 and over age adults ın antalya/turkey

Pages
371–377
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Influenza vaccine should be covered by health insurance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Influenza is a health threat to the elderly as it may lead to serious complications.
📊
Key Findings & Data:Studies demonstrated that influenza vaccination is safe and effective in preventing and controlling infection among the elderly.
💡
Conclusion & Impact:Influenza vaccine should be covered by health insurance.
🔬Design:Survey & Empirical Study
📍Scope:2005-2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Influenza is a health threat to the elderly as it may lead to serious complications. Studies demonstrated that influenza vaccination is safe and effective in preventing and controlling infection among the elderly. The aim of the study was to determine the vaccination status against influenza in the over 65 year-old age group in Antalya.Materials and Method: A total of 2383 individuals were surveyed during the 2005-2006 influenza season in Antalya, a city in the south of Turkey. The survey form included 14 questions about influenza vaccine.Results: Of the study sample, 55.7% were aware of the influenza vaccine. However, it was determined that only 15.0% had received an influenza vaccine.Conclusion: The study found that rate of influenza vaccination was low among adults aged sixty-five and over in Antalya. Physicians need to recommend the influenza vaccine especially to the elderly and public awareness should be increased. Influenza vaccine should be covered by health insurance.

Özet

Giriş: Grip, ciddi komplikasyonlara yol açabildiği için özellikle yaşlılarda bir sağlık tehdididir. Grip aşısının yaşlılarda infeksiyonun önlenmesinde ve kontrol edilmesinde güvenli ve etkili olduğunu çalışmalar da göstermiştir. Çalışmamızda Antalya'da 65 ve üzeri yaş grubunda grip aşısı ile bağışıklanma durumunun saptanması amaçlanmıştır.Gereç ve Yöntem: 2005-2006 yıllarında grip mevsimi boyunca Türkiye'nin güneyinde bir şehir olan Antalya'da toplam 2383 kişiye ulaşıldı. Araştırma formunda grip aşısıyla ilgili 14 soru vardı.Bulgular: Araştırma grubundakilerin %55.7'sinin grip aşısını duyduğu ve bildiği belirlendi. Ancak sadece gurubun %15'inin grip aşısı yaptırdığı saptandı.Sonuç: Antalya'da 65 yaş ve üzeri bireylerde grip aşısı yaptırma oranının düşük olduğu belirlenmiştir. Bu oranın artılması için doktorların özellikle yaşlılarda grip aşısını önermesi, halkın da bu konuda bilinçlendirilmesi ve grip aşısının sağlık sigortası kapsamına alınması gerekmektedir.

🔖

Cite This Article

POLAT, H. H., ÖNCEL, S., TURHAN, Ö., YALÇIN, A. N., ERAVŞAR, K., AKCAN, A. (2022). Antalya'da 65 yaş ve üzerindeki bireylerde grip aşısı ile bağışıklanma durumu. Türk Geriatri Dergisi, Cilt: 15 - Sayı: 4, 371–377. https://ajindex.com/articles/623978

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Aslan D, Ozcebe H, Temel F, et al. What influences physical activity among elders? A Turkish experience from Ankara, Tur- key. Archives Gerontology and Geriatrics 2008;46(1):79–88. (PMID:17482688). Lau JT, Yang X, Tsui HY, Kim JH. Prevalence of influenza vaccination and associated factors among community-dwelling Hong Kong residents of age 65 or above. Vaccine 2006;24(26):5526-34. (PMID:16716461). Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348(14):1322-32. (PMID:12672859). Nichol KL, Wuorenma J, Von Sternberg T. Benefits of influen- za vaccination for low-intermediate- and high-risk senior citi- zens. Arch Intern Med 1998;158(16):1769-76. (PMID:9738606). Nichol KL, Zimmerman R. Generalist and subspecialist physi- cians’ knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients. A nationwide survey. Arch Intern Med 2001;161(22):2702-8. (PMID:11732935). Horby PW, Williams A, Burgess MA, Wang H. Prevalence and determinants of influenza vaccination in Australians aged 40 years and over-a national survey. Aust N Z J Public Health 2005;29(1):35–7. (PMID:15782869). Lau JTF, Kim JH, Choi KC, Tsui HY, Yang X. Changes in pre- valence of influenza vaccination and strength of association of factors predicting influenza vaccination over time-Results of two population-based surveys. Vaccine 2007;25(49):8279-89. (PMID:17964010). Wodi AP, Sawsan S, Echezona E, et al. Influenza vaccine: im- munization rates, knowledge, and attitudes of resident physici- ans in an urban teaching hospital. Infect Control Hosp Epide- miol 2005;26:(11)867-73. (PMID:16320982). Glezen WP, Simonsen L. Commentary: Benefits of influenza vaccine in US elderly-new studies raise questions. International Journal of Epidemiology 2006;35(2):352-3. (PMID:16368723). Kanra G, Kara A. Influenza Immunization. Journal of Katk› Pediatrics Vaccines 1998;19(2-3):234-42.
  2. Singleton JA, Santibanez TA, Wortley PM. Influenza and pne- umococcal vaccination of adults aged ≥65. Am J Prev Med 2005;29(5):412-20. (PMID:16376704). Wang CS, Wang ST, Lai CT, Lin LJ, Lee CT, Chou P. Redu- cing major cause-specific hospitalization rates and shortening hospital stays after influenza vaccination. Clin Infect Dis 2004;39 (11):1604-10. (PMID:15578359). Hedlund J, Christenson B, Lundbergh P, Ortqvist A. Effects of a large-s